nonprofit logo

Access To Advanced Health Institute

Infectious Disease Research Institute

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 911608978 ✦ Seattle, WA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Access To Advanced Health Institute?

Access to Advanced Health Institute (AAHI) is a nonprofit biotech research institute, headquartered in Seattle, Washington, dedicated to developing vaccines, adjuvants, diagnostics, and drugs for preventing, detecting, and treating infectious diseases of global significance. AAHI's innovative RNA vaccine platform, based on self-amplifying RNA technology and a flexible nanostructured lipid carrier, sets it apart from existing licensed RNA vaccines. This technology could lead to vaccines with extended shelf life, the ability to be stored at room temperature, and faster manufacturing to address future pandemics. AAHI's scientists are currently advancing RNA vaccines against COVID-19, influenza, yellow fever, Zika, chikungunya, and HIV, and are adapting the platform for delivery by nasal spray or direct administration into tumors. Employing 79 dedicated professionals, AAHI's mission is to harness the immune system to alleviate disease and bring accessible, high-quality solutions to the global community.


Official website here: www.aahi.org

What are the reviews and ratings of this charity?

Charity Navigator rating: Zero-Star out of Four Stars (49%)

Access To Advanced Health Institute has received a Zero-Star rating from Charity Navigator, indicating significant concerns regarding its accountability and financial practices. The organization's score reflects a particularly troubling lack of independent board members and incomplete financial transparency, as evidenced by missing financial statements and documentation of board meeting minutes.

Despite its low rating, the organization does show a commendable program expense ratio of 71.37%, suggesting that a significant portion of its resources is directed toward its mission-related programs. Additionally, it has established conflict of interest, whistleblower, and document retention policies, which are positive organizational practices. However, the lack of independent oversight and financial documentation raises serious questions about governance and financial health.

Overall, while there are some strengths in its operational policies, the glaring deficiencies in board independence and financial disclosures contribute to a troubling rating. Potential donors should exercise caution and seek further information before considering support for this nonprofit.


This AI summary has been generated from information found on Charity Navigator.

Is Access To Advanced Health Institute legitimate?

Access To Advanced Health Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Access To Advanced Health Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $4,070,450
Professional Fundraising Fees: $0
Other Salaries and Wages: $5,577,081

For more financial information, click here


Official website here: www.aahi.org

What is the mission statement of Access To Advanced Health Institute?

Access to Advanced Health Institute is a non-profit biotech research institute dedicated to creating accessible, high-quality products and solutions to combat infectious diseases of global significance. The institute brings together leading experts, technologies, and platforms to harness the immune system and alleviate disease. Their focus on RNA vaccines sets them apart, with a self-amplifying RNA technology and nanostructured lipid carrier delivery system. This technology enables the vaccine to be stockpiled for extended periods, delivered at room temperature, and manufactured rapidly for addressing future pandemics. Researchers at the institute are developing RNA vaccines against various diseases, including COVID-19, influenza, yellow fever, Zika, Chikungunya, and HIV, and exploring nasal spray and direct tumor administration as delivery methods.


Official website here: www.aahi.org

Who is the CEO of Access To Advanced Health Institute?

Corey Casper is the CEO of Access To Advanced Health Institute The CEO's salary of Access To Advanced Health Institute is $542,213 and their total compensation is $583,676.


Official website here: www.aahi.org

What is the revenue of Access To Advanced Health Institute?

Access To Advanced Health Institute's revenue in 2023 was $22,776,375.


Official website here: www.aahi.org

Who are the executives of Access To Advanced Health Institute and what are their salaries?

The average compensation at Access To Advanced Health Institute during 2023 was $108,399. There are 89 employees and 6 volunteers at Access To Advanced Health Institute.

Here are 26 key members and their salaries (Access To Advanced Health Institute's CEO's salary is $542,213 and their total compensation is $583,676):


Corey Casper (Ceo, President)
  • Compensation: $542,213
  • Related: $0
  • Other: $41,463
Patrick Soon-Shiong (Board Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Kerr (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Edward Mocarski (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Edward Hsu (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Glenda Gray (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Raoul Concepcion (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Candice Decaire (Chief Strategy Officer, Secretary)
  • Compensation: $348,290
  • Related: $0
  • Other: $40,791
Jerry Kuo (Cfoo, V.P. & Treasurer)
  • Compensation: $344,534
  • Related: $0
  • Other: $55,747
Anna Marie Beckmann (Evp, Product Development)
  • Compensation: $280,027
  • Related: $0
  • Other: $42,086
Christopher Fox (Senior Vp Of Formulations)
  • Compensation: $236,068
  • Related: $0
  • Other: $55,214
Linda Hawkins (Senior Dir. Quality Assurance)
  • Compensation: $228,348
  • Related: $0
  • Other: $40,634
Robrick Smith (Director, Information Technology)
  • Compensation: $192,601
  • Related: $0
  • Other: $46,265
Suzan Snodgrass (Director, Finance)
  • Compensation: $184,714
  • Related: $0
  • Other: $33,380
Andrew Johnson (Associate Director, Program Mgmt)
  • Compensation: $176,746
  • Related: $0
  • Other: $23,630
Darren Klemkow (Dir. Facilities & Procurement)
  • Compensation: $167,930
  • Related: $0
  • Other: $22,557
Emily Voigt (Dir. Rna Program)
  • Compensation: $166,818
  • Related: $0
  • Other: $42,091
Lisa Mcneill (Dir. Manufacturing)
  • Compensation: $162,652
  • Related: $0
  • Other: $33,698
Lisa Bouchard (Dir. Quality Control)
  • Compensation: $156,372
  • Related: $0
  • Other: $31,035
Jeffrey Guderian (Dir. Laboratory Management)
  • Compensation: $154,096
  • Related: $0
  • Other: $31,704
Zachary Sagawa (Dir. Clinical Research & Reg. Affairs)
  • Compensation: $153,333
  • Related: $0
  • Other: $35,414
Damon Pang (Senior Corporate Counsel)
  • Compensation: $133,466
  • Related: $0
  • Other: $34,084
Cristina Goman (Clinical Trial Manager)
  • Compensation: $129,357
  • Related: $0
  • Other: $9,837
Robert Kinsey (Senior Manager, Formulations)
  • Compensation: $126,960
  • Related: $0
  • Other: $20,533
Amy Semenov (Dir. Human Resources)
  • Compensation: $124,625
  • Related: $0
  • Other: $36,039
Theresa Britschgi (Senior Project Manager)
  • Compensation: $124,110
  • Related: $0
  • Other: $20,445


Official website here: www.aahi.org

Where can I find the form 990 for Access To Advanced Health Institute?

Access To Advanced Health Institute's most recent form 990 was submitted in 2023 and can be accessed here.


Official website here: www.aahi.org

Learn more at the official website: www.aahi.org

Mission Statement of Access To Advanced Health Institute

Access to Advanced Health Institute (AAHI) is a renowned nonprofit biotech research institute, dedicated to bringing together top experts, technologies, and platforms to develop accessible, high-quality products and solutions for preventing, detecting, and treating infectious diseases of global significance.

At the heart of AAHI's mission lies the creation of vaccines, adjuvants, diagnostics, and drugs to combat infectious diseases. The institute's innovative approach harnesses the power of the immune system to alleviate diseases, focusing on creating accessible and effective solutions for the global community.

AAHI's research is centered around RNA vaccines, which have proven to be crucial tools in combating pandemics and have safely been administered to billions of people worldwide. AAHI's unique RNA vaccine platform, based on self-amplifying RNA technology and delivered by a flexible nanostructured lipid carrier, offers several advantages. The vaccine can be stockpiled for years, delivered at room temperature, and rapidly manufactured to address future pandemics. AAHI's scientists are currently advancing RNA vaccines against various diseases, including COVID-19, influenza, yellow fever, Zika, Chikungunya, and HIV, and exploring the possibility of delivering the platform via nasal spray or directly into tumors.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Access To Advanced Health Institute significantly impacts global health through the development of innovative vaccines, adjuvants, diagnostics, and treatments aimed at combating infectious diseases of global importance. Their pioneering work with RNA vaccines, particularly using a self-amplifying RNA technology, enhances the effectiveness and accessibility of vaccination programs. This platform not only ensures safety—having been reliably administered to billions worldwide—but also offers practical advantages, such as long-term stockpiling, room-temperature storage, and rapid manufacturing capabilities in response to emerging pandemics.

Among their key projects, AAHI is advancing RNA vaccines for critical diseases such as COVID-19, influenza, yellow fever, Zika, chikungunya, and HIV. Their innovations include the adaptation of vaccine delivery methods, considering options like nasal sprays and direct tumor administration, which could transform treatment protocols.

By consolidating expertise and cutting-edge technologies, Access To Advanced Health Institute is poised to improve health outcomes on a global scale, ultimately facilitating access to high-quality medical solutions for diverse populations facing infectious diseases. Their mission not only represents a leap in vaccine technology but also a commitment to harnessing the immune system effectively to alleviate significant health challenges.




This information is meant to be a general summary of Access To Advanced Health Institute. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$22,776,375 (2023)
2011201220132014201520162017201820192020202120222023$0$15M$30M$45M$60M
Expenses
$23,815,865 (2023)
2011201220132014201520162017201820192020202120222023$0$7.5M$15M$22.5M$30M
Efficiency
20112012201320142015201620172018201920202021202220230%15%30%45%68%

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $329,916
  • Program Service Revenue: $10,631,521
  • Gross Receipts: $23,393,018

Assets and Liabilities:

  • Total Assets: $42,840,477
  • Total Liabilities: $16,927,712
  • Net Assets: $25,912,765

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

LICENSING

Revenue

$6,212,068

SERVICES AND CONTRACTS

Revenue

$4,419,453

Organization Details

Founding Year

1993

Principal Officer

Jerry Kuo

Main Address

1616 EASTLAKE AVE E 400, SEATTLE, WA, 98102

NTEE Category

Code: H80 - Medical research

If you are a representative of Access To Advanced Health Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.